Arlington Partners’s Herbalife HLF Stock Holding History

Arlington Partners’s Portfolio HLF Stock Details HLF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-978	Closed	-$41K	–	679
2021 Q3	$41K	Buy	+978	New	+$48.4K	0.01%	283

Other funds holding HLF

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ROIC

Route One Investment Company San Francisco, California $2.35B AUM 11.7% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ACM

Alua Capital Management New York $1.13B AUM 8.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DVI

Deccan Value Investors Greenwich, Connecticut $84.6M AUM 57.32% 1-Year Est. Return

CIP

CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Arlington Partners's HLF Position: Q4 2021 in Review

Arlington Partners sold out of Herbalife (HLF) in Q4 2021, closing a stake of 978 shares — an estimated $41K sold.

Arlington Partners first reported a position in HLF in Q3 2021 and held it in 1 quarter. The position peaked at $41K in Q3 2021. 245 funds tracked by Wall St. Rank hold HLF as of Q4 2021.

Arlington Partners reported no remaining Herbalife position as of Q4 2021 after selling out during the quarter.
Arlington Partners sold 978 Herbalife shares in Q4 2021, an estimated $41K.
Arlington Partners first reported a position in Herbalife in Q3 2021 and held it in 1 quarter.
Arlington Partners's Herbalife position peaked at $41K in Q3 2021.
245 funds tracked by Wall St. Rank held Herbalife as of Q4 2021.

Based on Arlington Partners's 13F filing for Q4 2021, filed 18 Jan 2022.